NEUTRA CORP.
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About Neutra
Medicinal Chemicals & Botanical Products, SIC 2833
Neutra Corp. operates in the nutraceutical and cannabis sectors, focusing on products derived from natural and organic sources. The company primarily offers hemp-derived items, including products containing delta-8-THC, cannabidiol (CBD) sports creams, and other cannabinoids. In addition to commercializing products, it engages in research and development to introduce new technologies into the nutraceutical industry, targeting applications such as lighting, dosage devices, pesticide replacements, and plant enhancers. The company distributes its offerings to consumers both online through marketing agreements and under its own unique brands, utilizing third-party contract manufacturers for private-label production.
The company conducts its operations within the United States. Its corporate headquarters are located in Houston, Texas, and it operates a manufacturing facility in Katy, Texas. In addition to its direct operations, it maintains business assets through a subsidiary, Vivis Corporation, and engages in product sales via digital infrastructure.
Summary of the business section of Neutra's latest annual report, written by StockData.
Company profile
Company
- Legal name
- NEUTRA CORP.
- Founded
- 2011
- Headquarters
- Houston, TX
- Address
- 2500 Citywest Blvd., Ste 150-161 77042
- Phone
- (307) 228-1488
- Employees
- 15, Jan 31, 2022
- Industry
- Medicinal Chemicals & Botanical Products
- Incorporated in
- WY
- Fiscal year ends
- January 31
- Auditor
- M&K CPAS, PLLC, Houston, TX
Stock & identifiers
- Ticker
- NTRR
- Exchange
- OTC
- Shares outstanding
- 2.92B, Dec 15, 2023
- Public float
- $2.05M, Jul 31, 2022
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-50 reverse, Dec 21, 2015; 1-for-50 reverse, Oct 6, 2015; 1-for-20 reverse, Aug 8, 2012
- SEC CIK
- 1512886
- EIN
- 27-4505461
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Neutra's leadership is listed in its proxy statement (Form DEF 14A).
Employees
Headcount reported in annual reports
“We currently have 15 employees.”
Corporate history
Events identified from SEC filings